Publish Time: 2021-09-22 Origin: Site
The rapid development of my country's Semaglutide intermediates industry began in 2000. At present, there are about 2,000 kinds of raw materials and intermediates needed for the chemical industry every year, and the demand is more than 2.5 million tons. Up to now, the chemical raw materials and intermediates required by my country's pharmaceutical products can be matched, and only a small part needs to be imported. Moreover, due to my country's abundant resources and low raw material prices, many Semaglutide intermediates have achieved a large number of exports. Next, let's take a look at the characteristics and industry development trends of Semaglutide intermediates. Here are some answers.
Here is the content list:
l The production of Semaglutide intermediates in my country has six major characteristics.
l The development trend of the Semaglutide intermediates industry.
The production of Semaglutide intermediates in my country has six major characteristics.
One is that most of the manufacturers of pharmaceutical high purity powder semaglutide intermediates are private enterprises with flexible operation and small investment scale, basically between several million and ten to twenty million yuan. Second, the geographical distribution of production enterprises is relatively concentrated, mainly in areas centered on Taizhou, Zhejiang, and Jintan, Jiangsu. Third, as the country pays more and more attention to environmental protection issues, the pressure on manufacturing enterprises to build environmental protection treatment facilities has increased. Fourth, the product update speed is fast. Generally, after a product has been on the market for 3 to 5 years, its profit margin will drop significantly. This forces companies to continuously develop new products or continuously improve production processes to maintain high production profits. Fifth, because the production profit of Semaglutide intermediates is higher than that of chemical products, and the production processes of the two are the same, more and more small chemical companies have joined the ranks of producing pharmaceutical intermediates, resulting in increasingly fierce disorderly competition. Sixth, compared with APIs, API stable 98% semaglutide intermediates have a low-profit margin in the production of intermediates, and the production processes of APIs and pharmaceutical intermediates are similar. Therefore, some companies have not only produced intermediates but also used their advantages to start the production of APIs.
The development trend of Semaglutide intermediates industry.
With the continuous advancement of economic globalization, the division of labor and cooperation on a global scale has become increasingly obvious. Due to the long and complex characteristics of the industry chain, the fine chemical industry has the basis for the global division of labor and cooperation. To seize the highest point of profit, international industry giants have adjusted their development strategies, focusing their energy on the two ends of the smile curve-research and development and terminal products, while shifting the production links of glycolysis customized medical-grade semaglutide intermediates and APIs to the outside. The global division of labor has been formed. Due to their comparative advantages, developing countries such as China and India have a good foundation for undertaking the global industrial transfer. With the continuous improvement of China's fine chemical technology level, the types and market share of products that China undertakes industrial transfer are showing a gradual increase. In the process of fine chemical industry transfer, Semaglutide intermediates is a very important category, and it is also the main link for China to undertake transfer.
Our website is https://www.pu-kang.com/, if you are interested in lab synthesized long-acting semaglutide intermediates, you can contact us, welcome your visit, and look forward to cooperating with you.